DREAMM-5 platform trial: Belantamab mafodotin (belamaf; GSK2857916) in combination with five different novel agents in patients with relapsed/refractory multiple myeloma (RRMM)
Richardson, PG, Trudel, S, Callander, NS, Nooka, A, Song, K, Uttervall, K, Minnema, MC, Rodriguez-Otero, P, Struemper, H, Yeakey, A, de Oca, RM, Smith, LM, Jackson, N, Kaisermann, M, Im, E, Basile, FG, Ahlers, CM, Holkova, B, Gupta, I, Kremer, BE, Quach, H
Published in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Get full text
Published in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Conference Proceeding
Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis
Ho, J L, He, S, Hu, A, Geng, J, Basile, F G, Almeida, M G, Saito, A Y, Laurence, J, Johnson, Jr, W D
Published in The Journal of experimental medicine (01.04.1995)
Published in The Journal of experimental medicine (01.04.1995)
Get full text
Journal Article